28.2 Breast Pathology2
28.2 Breast Pathology2
1
7/6/2023
2
7/6/2023
Risk factors
• The origin of breast cancer is multifactorial and
involves diet, reproductive factors, and hormones
• Geographical variations
• Family history of breast ca (first degree relatives)
• Increase in age
– Rare before 25yrs of age
Risk Factors…
3
7/6/2023
Risk Factors…
• Endogenous hormones
– incidence rates of breast Ca rise more steeply with age; before
menopause (approximately 8% per year) than after menopause
(approximately 2% per year)
• Exogenous estrogen
– Unopposed estrogen therapy, Oral contraceptives, Postmenopausal hormone-
replacement therapy (HRT)
– ARC has concluded that the combination of estrogen plus progestin is
carcinogenic to humans (class 1 carcinogen). In addition, unopposed
estrogen therapy increases the risk of breast cancer, with risk augmenting
with duration of use (higher risk for current or recent user). Furthermore,
this rise in risk is greatest among lean women, who have low levels of
circulating estrogen due to their low body mass.
7
Reading assignment
4
7/6/2023
Risk Factors…
5
7/6/2023
11
Hereditary/familial
breast cancer
• Two high-penetrance genes have been
identified (BRCA1 and BRCA2)
• Additional polymorphisms and genes
have been recently identified. evidence
suggests a polygenic origin for this
disease
• About 25% of familial cancers (~3% of all
breast cancers) are due to BRCA1 and
BRCA2
• The general lifetime risk for female
carriers is 30-90%
12
6
7/6/2023
13
7
7/6/2023
15
Carcinoma of the
breast
Classification and distribution of breast cancers
- 95% are adenocarcinomas
16
8
7/6/2023
17
18
9
7/6/2023
19
20
10
7/6/2023
21
22
11
7/6/2023
23
24
12
7/6/2023
25
26
13
7/6/2023
27
28
14
7/6/2023
29
30
15
7/6/2023
31
32
16
7/6/2023
33
Invasive Carcinomas
Invasive ductal carcinoma , No special type
- These include the majority of carcinoma (70% to 80%)
that cannot be classified as any other type.
34
17
7/6/2023
Morphology
35
36
18
7/6/2023
37
38
19
7/6/2023
39
40
20
7/6/2023
21
7/6/2023
Morphology
44
22
7/6/2023
45
46
23
7/6/2023
47
48
24
7/6/2023
49
50
25
7/6/2023
51
52
26
7/6/2023
53
Indian file
27
7/6/2023
Tubular carcinoma
- practically well- differentiated carcinoma with good
prognosis
Medullary carcinoma
Mucinous or colloid carcinoma
Invasive papillary carcinoma
Metaplastic carcinoma
55
56
28
7/6/2023
57
58
29
7/6/2023
59
60
30
7/6/2023
61
62
31
7/6/2023
63
Molecular Subtypes of
Invasive Breast Cancer
• Molecular subtypes highlights potential new therapeutic
targets (anti-hormonal or anti HER-2 therapy)
ER –ve
ER +ve
ER induced expression PR-
of Progesterone no ER action; poor
receptor (PR+) outcome 64
32
7/6/2023
Molecular subtype …
HER-2
HER-2 –ve ER –ve TNBC
HER-2 +ve
HER-2 -ve - Poor natural HER-2 +ve ER +ve Luminal A
history;
- anti HER-2 Luminal B
therapy
Molecular subtype …
Luminal A Luminal B
33
7/6/2023
67
Stromal Tumors
• Two types of breast stroma, Intralobular & interlobular , give
rise to distinct types of neoplasms
68
34
7/6/2023
Stromal Tumors
• Breast - specific biphasic tumors fibroadenoma & phyllodes
tumor arise in the intralobular stroma
69
Fibroadenoma
• the most common benign tumor of the female breast
• more common before age 30,but can occur at any age of
reproductive life
• frequently multiple & bilateral
• The epithelium of the fibroadenoma is hormonally responsive
• The stroma only is neoplastic
70
35
7/6/2023
Morphology
Gross - Spherical nodules usually sharply circumscribed &
freely movable in the surrounding breast substance
71
72
36
7/6/2023
73
74
37
7/6/2023
75
76
38
7/6/2023
77
78
39
7/6/2023
Usual Age 15-25, usually puberty 30-50, regress after 30-90, most common over
and young adulthood, but menopause except with age 50
up to age 55 estrogen therapy
Number Usually single, may be Single or multiple Usually single, may coexist
multiple with other nodules
Shape Round, disclike, or lobular Round Irregular or stellate
Consistency May be soft, usually firm Soft to firm, usually elastic Firm or hard
Delimitation Well delineated Well delineated Not clearly delineated from
surrounding tissues
Mobility Very mobile Mobile May be fixed to skin or
underlying tissues
Tenderness Usually nontender Often tender Usually nontender
Retraction Signs Absent Absent May be present
79
Phyllodes Tumor
• Although they can occur at any age, most present in the
sixth decade
• Most present as palpable mass
• They are low grade neoplasms which rarely metastasize
80
40
7/6/2023
Morphology
• vary in size from a few centimeters to massive lesions
involving the entire breast
• The larger lesions often have bulbous protrusions
(phyllodes is Greek for “leaflike”) due to presence of
nodules of proliferating stroma covered by epithelium
81
82
41
7/6/2023
83
84
42
7/6/2023
85
86
43
7/6/2023
87
88
44
7/6/2023
89
90
45
7/6/2023
91
92
46
7/6/2023
93
94
47
7/6/2023
Gynecomastia
• enlargement of the male breast may be unilateral or
bilateral
• Presents as button-like subareolar enlargement
• may occur as result of imbalance between estrogens ,
which stimulate breast tissue, & androgens which
counteract these effects
• At puberty or any time during adult life when there is
hyperestrinism
95
96
48
7/6/2023
97
98
49
7/6/2023
99
100
50
7/6/2023
101
102
51
7/6/2023
103
104
52
7/6/2023
105
106
53
7/6/2023
107
108
54
7/6/2023
109
110
55